Poster Abstracts

ESVC – European Society of Veterinary Cardiology
ESVC-P-1 Kiss Cilostazol as medical treatment of bradycardia of cardiac origin in dogs
ESVC-P-2 Alibrandi Smartphone-based 6-lead ECG: a new device for electrocardiographic recording in dogs
ESVC-P-3 Costa-Rodríguez Correlation of serum N-terminal pro B-type natriuretic peptide with pulmonary hypertension in heartworm-infected dogs during adulticide treatment
ESVC-P-4 Kempker The good, the bad and the breeder - Development of genetic HCM-variants in cat populations from routine testing in the last 10 years
ESVC-P-6 Baisan Assessment of precordial R-peak time in dogs with left sided volume overload secondary to myxomatous mitral valve disease and dilated cardiomyopathy
ESVC-P-7 Cimerman Inflammatory and immune variables as predictors of survival in dogs with myxomatous mitral valve disease
ESVC-P-8 Romito Clinical findings and outcome in 27 cats with transient myocardial thickening
ESVC-P-9 Falcón Cordón Associations between thoracic radiographic changes and severity of pulmonary hypertension diagnosed via Doppler echocardiography in dogs with heartworm disease (Dirofilaria immitis). 
ESVC-P-10 Georgiades Clinical presentation and survival in dogs with acquired atrial septal defect secondary to myxomatous mitral valve disease
ESVC-P-11 Davis Echocardiographic classification of dogs with aortic stenosis: potential utility of a novel staging system 
ESVC-P-12 Sakarin Serum proteomic profiles in dogs affected with pulmonary hypertension secondary to degenerative mitral valve disease
ESVC-P-13 Välimäki The impact of intravenous medetomidine and vatinoxan on echocardiographic evaluation of dogs with ACVIM stage B1 mitral valve disease
ESVC-P-14 Santana Percutaneous closure of patent ductus arteriosus with the Vet-PDA Occluder® device in dog
ESVC-P-15 Szatmari How do practicing veterinarians treat stage B and C myxomatous mitral valve degeneration in dogs?
ESVC-P-16 Van Renterghem Ratio of tricuspid annular plane systolic excursion on systolic pulmonary arterial pressure as a prognostic factor in canine pre-capillary pulmonary hypertension
ESVC-P-17 Panprom The effect of anesthesia drug on cardiac function parameters in cats
ESVC-P-18 Chang Aortic insufficiency in dogs and cats: A retrospective study of clinical characteristics, echocardiographic findings, and prognosis in non-infectious and non-congenital cases
ESVC-P-19 Di Grado Respiratory rate and breathing pattern in dogs and cats admitted to the intensive care unit at two small animal hospitals in Sweden.
ESVC-P-20 Lee Temporal cardiomegaly induced by non-cardiogenic respiratory distress in dogs with myxomatous mitral valve disease
ESVC-P-21 Legrand Association of decreased bodyweight-independent tricuspid annular plane systolic excursion (TAPSE) measured in M-mode with clinical signs of heart failure and cardiac death in dogs with pre-capillary pulmonary hypertension. 
ESVC-P-22 Baisan Respiratory Sinus Arrhythmia Dynamics in Dogs with Various Classes of Naturally Occurring Myxomatous Mitral Valve Disease
ESVC-P-23 Sukumolanan Proteomics and coagulation markers in cats with asymptomatic and symptomatic hypertrophic cardiomyopathy
ESVC-P-24 Matos Rivero Clinical and echocardiographic findings in dogs with heartworm caval syndrome
ESVC-P-25 Iwasa The prognostic value of circulating cardiac and renal biomarkers in dogs with myxomatous mitral valve disease
SCH – Society of Comparative Hepatology 
SCH-P-1 Cattaneo A retrospective study investigating the grade and temporal progression of feline gall bladder sludge and association with concurrent disease
SCH-P-2 Jolly-Frahija Biliary hamartoma: a case series in small animals
ESVCP – European Society of Veterinary Clinical Pathology
ESVCP-P-1 Le boedec Performance of predicted ionized calcium (piCa) in dogs with ambiguous prediction interval results
ESVCP-P-2 Gori Is the erythrocyte sedimentation rate (ESR) a reliable inflammatory marker in cats?
ESVCP-P-3 Rickards Frequency of healthy dogs with normal creatinine measurement and IRIS stage II categorisation using a point-of-care analyser
ESVCP-P-4 Steffensen Immune-modulatory effect of doxycycline on canine neutrophils: Impact on neutrophil extracellular trap formation, reactive oxygen species production and killing efficiency on Staphylococcus aureus
ESVNU – European Society of Veterinary Nephrology and Urology
ESVNU-P-1 Gil Capillary electrophoresis in urine from healthy cats: comparison with canine patterns
ESVNU-P-2 Lea One-step, non-surgical placement of permanent low-profile cystostomy tubes in nine dogs
ESVNU-P-3 Liu Comparison between urine protein-creatinine ratios of samples obtained from healthy cats at home and in hospital.
ESVNU-P-4 Bestwick The prevalence of disease in diagnosis-naïve older cats presented for health screening to two UK-based veterinary clinics
ESVNU-P-5 Jaturanratsamee Ultrasound assessments of cats associated with polycystic kidney disease caused by feline PKD1 genetic mutation
ESVNU-P-6 Schäfer Association of Fibroblast growth factor-23 (FGF-23) with parameters of renal dysfunction in dogs and cats
ESVNU-P-7 Daza Alterations in canine magnesium levels caused by Leishmania infantum-induced chronic renal disease
ESVNU-P-8 Vigouroux Effect of subcutaneous bypass (SUB) on proteinuria in cats with ureteral obstruction.
ESVNU-P-9 Daza Development of Cardiorenal Syndrome type IV (Chronic renocardiac syndrome) in cats attended to a nephrology service
ESCG – European Society of Comparative Gastroenterology
ESCG-P-1 Chrysovergi Serial evaluation of the effects of antibiotic use on the intestinal microbiome in kittens   using the feline dysbiosis index
ESCG-P-2 Moraiti Serial measurement of serum specific pancreatic lipase and trypsin-like immunoreactivity concentrations in dogs and cats with diabetes mellitus
ESCG-P-3 Holmberg Comparative study of video capsule endoscopy findings in dogs with chronic enteropathy and in healthy dogs
ESCG-P-4 Mathews Characterization of the intestinal microbiome of dogs with inflammatory brain disease compared to dogs with non-inflammatory brain disease and healthy control dogs
ESCG-P-5 Díaz-Regañón Interrelation between microbiota and intraepithelial and lamina propria duodenal T-lymphocytes in dogs with inflammatory bowel disease
ESCG-P-6 Karra Evaluation of fecal microbiota transplantation as adjunct management of cats with chronic enteropathies in a controlled, blinded, randomized clinical trial
ESCG-P-7 Ludvigsson Chronic enteropathy and emotional health in dogs - a prospective comparative pilot study 
ESCG-P-8 Peyron Overview of faecal pathogens isolated from faeces of French young cats and dogs using PCR technique over a year (2022)
ESCG-P-9 Karra Serial measurement of serum-specific pancreatic lipase and trypsin-like immunoreactivity concentrations in cats during treatment for chronic enteropathy 
ESCG-P-10 Tang Relationship between 1,2-O-dilauryl-rac-glycero glutaric acid-(6’-methylresorufin) ester (DGGR) lipase activity and clinical signs in dogs with chronic gastrointestinal signs over time
ESCG-P-11 Cocci Prevalence of duodenal lymphangiectasia in French Bulldogs with obstructive airway syndrome undergoing endoscopic examination of the respiratory tract and upper digestive tract: retrospective study in 29 cases (2021-2022)
ESCG-P-12 Spalla Holter analysis in dogs with acute and chronic diarrhea
ESCG-P-13 Keller Psyllium husk powder increases defecation frequency and fecal score, bulk and moisture in healthy cats
ESCG-P-14 Hanifeh Fecal microbiota transplantation in dogs with tylosin responsive enteropathy - A proof of concept study
ESCG-P-15 Signorelli Characterization of underlying causes, treatment approaches, short and long-term outcome in young cats with chronic recurrent gastrointestinal signs 
ESCG-P-16 Correa Lopes Effect of various storage conditions on bacteria viability in fecal microbiota transplantation preparations
ESCG-P-17 Méric Fecal proteolytic activities in dogs with chronic inflammatory enteropathies
ESCG-P-18 Smith Protein-losing enteropathy in Pugs: a different form of disease?
ESCG-P-19 Hawes Mortality rate and associated characteristics prior to hospital discharge in dogs with protein-losing enteropathy
ISCAID – International Society for Companion Animal Infectious Diseases
ISCAID-P-1 Breu Seroprevalence of toxoplasma-specific antibodies in European cats suspected of toxoplasmosis 
ISCAID-P-2 Khor Serum cardiac troponin I as an indicator of myocarditis in dogs diagnosed with leptospirosis
ISCAID-P-3 Pavlin Dynamics of selected inflammatory markers during treatment of feline infectious peritonitis
ISCAID-P-4 Boontuboon The association between immune-mediated thrombocytopenia diagnosed by flow cytometry and canine monocytic ehrlichiosis
ISCAID-P-5 Fastrès Impact of DNA extraction methods and culture-independent approaches on canine lung mycobiota analysis 
ISCAID-P-6 Thomsen Characterisation of Clinical Bleeding Diathesis, and Laboratory Haemostatic Aberrations and Survival in 180 Dogs (2005-2019) Naturally Infected with Angiostrongylus vasorum 
ISCAID-P-8 Kehl Resistance of Leishmania infantum to allopurinol in dogs in Europe – a digital droplet PCR assay for quantifying S-adenosylmethionine synthetase (METK) gene copy number
ISCAID-P-10 Roels Prevalence and risk factors for Mycoplasma spp. positivity in cat blood donor units from Portugal, Spain and Belgium in 2022: retrospective study on 7573 blood donations from 4121 healthy donor cats 
ISCAID-P-11 Wilczek A multivalent vaccine against Lyme borreliosis applied to dogs using different vaccination schedules: characterization of the humoral immune response
ISCAID-P-12 Tam Leptospira in dogs in Hong Kong: serology and urinary shedding 
ISCAID-P-13 Murillo Leishmania infantum specific IL-2 production after oclacitinib and ciclosporin  treatments in ex vivo stimulated canine blood
ISCAID-P-14 GONZÁLEZ Evaluation of complementary stem cell therapy in the treatment of kidney disease secondary to canine leishmaniasis
ISCAID-P-15 Tangmahakul Advantage of matrix-assisted laser desorption/ionization time-of-flight (MALDI-TOF) mass spectrometry for bacterial identification in cats with pyothorax
ISCAID-P-16 Jiménez The effect of oclacitinib and ciclosporin A on IL-17a production against Leishmania infantum stimulated canine blood
ISCAID-P-17 Gori Serum amino acid profile in canine sepsis and its relationship with survival
ISCAID-P-18 Mateu Comparison of Real-Time PCR and culture of bronchoalveolar lavage fluid in dogs for the detection of Bordetella bronchiseptica infection: a retrospective study of 12 cases. 
ISCAID-P-19 García Rodríguez Co-infections and risk factors in stray cats in Gran Canaria (Spain): Dirofilaria immitis, Bartonella henselae, feline leukemia and feline immunodeficiency.
ESVIM – European Society of Veterinary Internal Medicine 
ESVIM-P-1 García-Guasch Characterisation of brachycephalic obstructive airway syndrome in cats using barometric whole-body plethysmography
ESVIM-P-2 PETITPRE Dorsomedial nasopharyngeal masses with a benign appearance in dogs: a retrospective study of 99 cases (2019-2022).
ESVIM-P-3 Grobman Incidence and characterization of aerophagia in dogs using videofluoroscopic swallow studies
ESVIM-P-4 Chen Spectrographic analysis of lung sound for identifying visual characteristics of crackles in dogs
ESVIM-P-5 Bottero Clinical evaluation and endoscopic classification of gastrointestinal findings in 220 dogs with brachicephalic syndrome.
ESVIM-P-6 Geisen Heinz Body Formation in 13 Multimorbid Dogs following Metamizole Administration
ESVIM-P-7 Schortz Root cause analysis of medication-related incidents in small animal veterinary practices: An Analysis of Incident Reports
ESVIM-P-8 Jaffey Effects of short-term oral 25-hydroxyvitamin D supplementation on leukocyte cytokine production in healthy dogs
ESVIM-P-9 Viitanen Serum procalcitonin as a diagnostic biomarker in dogs with bacterial respiratory diseases
ESVIM-P-11 SU Clinical efficacy of feline recombinant interferon-omega as an additional agent in refractory feline chronic gingivostomatitis
ESVIM-P-12 Doulidis Determination of the plasma proteome of healthy dogs using Liquid Chromatography - Mass spectrometry.
ESVIM-P-13 Ostronic Pharmacodynamics of Standard and Low Dose Once Daily Esomeprazole in Healthy, Medium to Large Breed Dogs 
ESVIM-P-16 Gaspar Current epidemiology and therapeutic trends of feline chronic rhinitis - a retrospective study
ESVIM-P-17 Carvalho Owners’ perspective about the use of mirtazapine transdermal ointment in cats – a survey-based study
ESVIM-P-18 López Bailén Outcome and prognostic factors in dogs diagnosed with immune-mediated thrombocytopenia in Ireland (2009-2020)
ESVIM-P-19 Pimenta da Silva evaluation of association between hemoparasite infection risk and blood phenotype, gender and breed in potential feline blood donors of portugal and spain
ESVIM-P-20 Álvarez Prevalence, age and disease associations in Yorkshire terriers with increased blood urea nitrogen
ESVIM-P-22 Mateu Clinical and imaging findings, bacterial isolates and antimicrobial resistance in 14 dogs with tracheal and/or bronchial collapse: a retrospective study of 14 cases. 
ESVIM-P-23 Boot Clinical manifestations, endoscopic findings and outcome of palatine tonsil crypt foreign bodies in dogs: 7 cases (2020-2022)
ESVONC – European Society of Veterinary Oncology
ESVONC-P-1 Kleiter Implementation of an Elekta Infinity linear accelerator with advanced treatment technology
ESVONC-P-2 Marceglia Platelet count changes in cats with lymphoma following repeated vincristine administration.
ESVONC-P-3 Einhorn Outcomes and prognostic factors in canine T cell lymphoma treated with lomustine, vincristine, cyclophosphamide, and prednisone chemotherapy
ESVONC-P-4 Tena Incidence of elevated serum symmetric dimethylarginine in Australian dogs with multicentric large B-cell lymphoma 
ESVONC-P-5 Treggiari Retrospective evaluation of lung lobectomy and adjuvant treatment for primary pulmonary carcinoma in dogs: a multi-institutional study 
ESVONC-P-6 Hanael Thermographic assessment of soft tissue sarcomas in dogs. 
ESVONC-P-7 Odatzoglou Feasibility of using flow cytometric analysis of Ki-67 expression in canine cutaneous mast cell tumours - a pilot study
ESVONC-P-8 Lollo Round cell tumours and the feline tarsus: a fatal attraction
ESVONC-P-9 Ramos Surgery and Adjuvant Electrochemotherapy Compared to Surgery Alone for Treatment of Canine Soft Tissue Sarcomas
ESVONC-P-10 Hawkes Evaluation of staging in 504 dogs with aggressive peripheral nodal B cell lymphoma across 16 Oncology referral centres.  
ESVONC-P-11 Ghisoni a retrospective clinico-pathologic study of 37 dogs with urethral carcinoma (2012 - 2022)
ESVONC-P-12 Larsen A retrospective study of clinical outcome in response to short chemotherapy protocol for feline intermediate- and large cell lymphoma
ESVONC-P-13 Mulder Erythrocyte and platelet characteristics as indicators of metastasis in canine carcinomas and sarcomas
ESVONC-P-14 Del Castillo Is Chemotherapy Useful In Feline Mammary Tumours?
ESVONC-P-15 Garcia-de la Virgen Toceranib (Palladia®) as a first line therapy in macroscopic canine oral squamous cell carcinoma: a case series
ESVONC-P-16 Vázquez-Martínez Evaluation of the CLOP protocol as induction in canine non-indolent T-cell lymphoma
ESVE – European Society of Veterinary Endocrinology
ESVE-P-1 Galdhar  Radioimmunoassay (RIA) enabled thyroid profile in healthy dogs: effect of age, sex, breed, and diet
ESVE-P-2 Bennaim Machine-learning as a diagnostic tool for naturally occurring hypercortisolism in dogs
ESVE-P-3 Reeves A prospective study to examine the natural variation of interstitial glucose levels in healthy adult dogs utilising a continuous glucose monitoring system. 

ESVE-P-4 Guse Signalment, clinicopathological findings, management practices and occurrence of comorbidities in cats with diabetes mellitus in Germany: prospective study of 148 cases
ESVE-P-5 Egbert Thyroid hormone concentrations in healthy Irish Setters and Rhodesian Ridgeback dogs: a diagnostic comparison
ESVE-P-6 Carvalho Interpretation of screening tests for hypercortisolism by first-opinion western european veterinary surgeons
ESVE-P-8 Stadler Perceptions of first-opinion veterinarians and owners in Switzerland about treatment of feline hyperthyroidism 
ESVE-P-9 Kurtz Urinary aldosterone to creatinine ratio and fractional excretion of sodium and potassium in healthy cats, cats with primary hyperaldosteronism and cats with secondary hyperaldosteronism
ESVE-P-10 Blunschi The effect of treatment modality on changes in quality of life in hyperthyroid cats
ESVE-P-11 López-Gómez Hypercortisolism in cats in relation with diabetes mellitus: clinical and laboratory abnormalities, blood pressure and survival under trilostane treatment.
ESVE-P-12 Martineau Addison Detect: a machine learning predictive model web application to assess canine hypoadrenocorticism likelihood using signalment and routine bloodwork results
ESVE-P-13 Norman Longitudinal evaluation of blood pressure in cats treated for hyperthyroidism.
ESVE-P-14 Miceli Feline hypersomatotropism without concurrent diabetes mellitus: 21 cases (2014-2023)
ESVE-P-15 Rothlin Zachrisson Stress or success – hair cortisol concentrations in relation to cat characteristics, health and reproductive status in cats
ESVE-P-16 Del Baldo evaluation of urinary corticoid-to-creatinine ratio using a canine-specific chemiluminescent cortisol assay (immulite 2000) in the diagnosis of canine hypercortisolism
ESVE-P-17 Slon Circulating concentrations of betatrophin in dogs with diabetes mellitus
ESVE-P-18 Rey Amunategui Comparison of symmetric dimethylarginine, plasma aldosterone concentration, renin activity and systolic blood pressure between diabetic and non-diabetic cats with hypersomatotropism
ESVE-P-19 Rey Amunategui Increased insulin-like growth factor 1 concentrations in a population of non-diabetic cats with chronic kidney disease
ESVE-P-20 Allenspach Healthy Canine and Human Derived Pituitary Gland Organoids Exhibit Comparable Cellular Complexity and Hormone Secretion
ESVE-P-21 Strey Canine hypoadrenocorticism – evaluation of aldosterone concentration and thyroid autoantibodies in dogs  
ESVE-P-22 Nagata Urinary steroid profiling using liquid chromatography-tandem mass spectrometry for the diagnosis of canine Cushing’s syndrome
ESVE-P-23 Hulsebosch Normal thyroid values in 3-week and 8-week-old healthy kittens 
ESVE-P-24 Langlois Desoxycorticosterone pivalate (DOCP) pharmacodynamics in dogs with hypoadrenocorticism